Giatro, S.M.; Komontachakis, G.; Kalantidou, A.; Lesgidou, N.; Karageorgos, V.; Teleb, M.; Islam, M.R.; Mavromoustakos, T.; Fahmy, H.; Venihaki, M.;
et al. Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43. Biomolecules 2025, 15, 1265.
https://doi.org/10.3390/biom15091265
AMA Style
Giatro SM, Komontachakis G, Kalantidou A, Lesgidou N, Karageorgos V, Teleb M, Islam MR, Mavromoustakos T, Fahmy H, Venihaki M,
et al. Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43. Biomolecules. 2025; 15(9):1265.
https://doi.org/10.3390/biom15091265
Chicago/Turabian Style
Giatro, Spyridon Marios, George Komontachakis, Aikaterini Kalantidou, Nastazia Lesgidou, Vlasios Karageorgos, Mohamed Teleb, Md Rabiul Islam, Thomas Mavromoustakos, Hesham Fahmy, Maria Venihaki,
and et al. 2025. "Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43" Biomolecules 15, no. 9: 1265.
https://doi.org/10.3390/biom15091265
APA Style
Giatro, S. M., Komontachakis, G., Kalantidou, A., Lesgidou, N., Karageorgos, V., Teleb, M., Islam, M. R., Mavromoustakos, T., Fahmy, H., Venihaki, M., Matsoukas, M.-T., & Liapakis, G.
(2025). Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43. Biomolecules, 15(9), 1265.
https://doi.org/10.3390/biom15091265
